Bassler Bonnie L 4

What Happened

• Bonnie L. Bassler, a director of Royalty Pharma plc (RPRX), was issued 815 Class A Ordinary Shares on 2026-03-31 as an award (transaction code A). The filing lists a per-share value of $45.98, for a total reported value of $37,471.
• This issuance was a compensation grant—shares were issued in lieu of a quarterly cash retainer—not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-31; Price/value reported: $45.98 per share; total value: $37,471.
• Shares issued: 815 Class A Ordinary Shares.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnote: The shares were issued under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a $37,500 quarterly retainer (per footnote F1).
• Filing timeliness: Reported on 2026-03-31 (no late filing indicated).

Context

• Equity awards issued to directors in lieu of cash retainers are a common form of compensation and generally reflect routine corporate governance practices rather than a direct buy/sell signal about the company's near-term prospects.
• This was an award/grant (code A) — not a purchase (P) or sale (S) — so it should be interpreted as compensation, not insider buying or selling activity.